{"title":"Cavernous sinus hemodynamic buffering model (CSHBM): a novel hypothesis for neurovascular protection","authors":"Guive Sharifi , Khatere Mokhtari","doi":"10.1016/j.mehy.2025.111779","DOIUrl":"10.1016/j.mehy.2025.111779","url":null,"abstract":"<div><div>The cavernous sinus (CS) is an anatomically complex venous plexus located at the base of the skull, closely associated with the internal carotid artery (ICA) and cranial nerves controlling ocular movement and facial sensation. We propose the Cavernous Sinus Hemodynamic Buffering Model (CSHBM), hypothesizing that the CS acts as a dynamic hemodynamic buffer protecting these vital neurovascular structures from the pulsatile forces generated by the ICA and external mechanical stresses. According to this model, the venous blood acts as a viscoelastic cushion, and together with the trabeculated architecture and compliant walls of the sinus, facilitates absorption, attenuation, and gradual dissipation of arterial pulsatile energy. This mechanism reduces mechanical strain on adjacent cranial nerves and preserves microvascular stability. The model underscores a potentially underappreciated neuroprotective role of the CS, particularly relevant in pathologies such as carotid-cavernous fistulas and thrombosis. This hypothesis can be evaluated using computational fluid dynamics (CFD), fluid–structure interaction (FSI) modeling, and advanced imaging modalities like 4D Flow MRI and phase-contrast MRI to assess pressure dynamics and flow modulation within the cavernous sinus. Understanding this buffering function may provide new insights into cavernous sinus pathophysiology and inform future diagnostic and therapeutic approaches.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111779"},"PeriodicalIF":0.8,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145269806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A diametrically opposed view of the role of glucocorticoids in central serous chorioretinopathy","authors":"F. Behar-Cohen","doi":"10.1016/j.mehy.2025.111777","DOIUrl":"10.1016/j.mehy.2025.111777","url":null,"abstract":"<div><div>Central serous chorioretinopathy (CSCR) is traditionally linked to glucocorticoid (GC) excess. We propose the opposite: in predisposed individuals, subtle hypothalamic–pituitary–adrenal (HPA) axis suppression—triggered by systemic GC exposure or maladaptive stress responses—lowers intraocular cortisol, shifts the glucocorticoid/mineralocorticoid receptor balance, and drives mineralocorticoid receptor (MR) overactivation in the retinal pigment epithelium–choroid complex. This cascade induces choroidal neuropathy, pachychoroid phenotype, and retinal pigment epithelium (RPE) barrier breakdown. Experimental models, biomarker studies, and metabolomic data support this mechanism, reconciling why systemic but not intraocular GCs are associated with CSCR. If confirmed, this paradigm shift would favor cautious GC tapering, local ocular GC supplementation, and MR antagonism as targeted therapeutic strategies.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111777"},"PeriodicalIF":0.8,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Metabolic immunobridge: Could adipose-derived extracellular vesicles be the missing link between obesity, autoimmunity, and drug-induced hepatotoxicity?","authors":"Okechukwu Paul-Chima Ugwu, Fabian Chukwudi Ogenyi, Chinyere Nneoma Ugwu, Samanya Bulhan","doi":"10.1016/j.mehy.2025.111776","DOIUrl":"10.1016/j.mehy.2025.111776","url":null,"abstract":"<div><div>Obesity is now being viewed as a systemic immunometabolic disease, but the mediators through which adipose dysfunction is associated with immune dysregulation and liver damage are still not fully known. Our hypothesis is that lipid-enriched adipose-derived extracellular vesicles (EVs), containing microRNAs and damage-associated molecular patterns, are a metabolic immunobridge between obesity, autoimmunity, and hepatotoxicity caused by drugs. In contrast to previous models, like the one described by Malaguarnera et al., which in depth analysed the contribution of the two types of EV to autoimmunity differences between brown and white adipose tissue, we concentrate on the new postulate that EV cargo can co-stimulate autoimmunity and reduce the hepatic threshold of drug injury, and therefore unite two different pathological risks into a single explanatory model. The integrative viewpoint is a step further in the literature since it focuses on EV-mediated cross-talk not only between adipocytes and immune cells but also between immune-primed conditions and hepatocellular susceptibility. Provided as validated, this framework would offer new information on why obese people are more susceptible to autoimmune diseases and experience disproportionate severity of drug-induced liver injury (DILI). Furthermore, EVs could serve as predictive biomarkers and therapeutic targets for immune hepatic disorders associated with obesity.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111776"},"PeriodicalIF":0.8,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Facial asymmetry from one-sided sleep? A hypothesis linking REM activity and muscle hypertrophy","authors":"Andrew James Swift","doi":"10.1016/j.mehy.2025.111775","DOIUrl":"10.1016/j.mehy.2025.111775","url":null,"abstract":"<div><div>Facial asymmetry is a common but underexplored phenomenon. While often attributed to skeletal or developmental variation, this paper presents a novel theoretical mechanism that may account for progressive neuromuscular asymmetry in individuals who habitually sleep on one side. We propose that repeated facial muscle activation during REM sleep, combined with unilateral compression from habitual side-sleeping, may cause long-term asymmetrical hypertrophy of facial muscles. Drawing from anatomical, physiological, and observational insights, this hypothesis is grounded in known features of REM sleep including eye movement, facial expression, and partial motor activation. The paper explores possible implications for emotional expressivity and psychosocial identity, supported by an anonymised case. Future research avenues are proposed for validating this hypothesis, with relevance to sleep medicine, affective neuroscience, and facial physiology.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111775"},"PeriodicalIF":0.8,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Brain-Heart-Kidney Axis: a unified theory of systemic small vessel disease in CSVD","authors":"Tie-Qiang Li , Jiaxin Liu , Caijing Zhuo","doi":"10.1016/j.mehy.2025.111774","DOIUrl":"10.1016/j.mehy.2025.111774","url":null,"abstract":"<div><div>Cerebral small vessel disease (CSVD) is a systemic small vessel disease syndrome driven by an interdependent brain–heart-kidney axis. Microvascular damage is mediated by endothelial nitric oxide synthase (eNOS) dysfunction, NF-κB-driven inflammation, and reactive oxygen species (ROS)-induced oxidative stress, amplified by genetic variants (NOS3, APOE, NOTCH3) and peripheral nervous system dysregulation. We predict 50–70% overlap among CSVD, coronary microvascular dysfunction, and chronic kidney disease, with gait disturbances and urinary dysfunction reflecting PNS and kidney involvement. Validation involves molecular profiling, multimodal imaging (MRI, cardiac MRI, renal ultrasound), and longitudinal studies. This model, inspired by multi-organ frameworks like Parkinson’s disease but distinct due to CSVD’s microvascular focus, guides integrated diagnostics, targeted therapies (eNOS enhancers, statins), and prevention strategies for systemic small vessel disease syndrome.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111774"},"PeriodicalIF":0.8,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CNS-derived microparticles: a hypothesis for biomarker-based assessment of neurological complications in β-thalassemia","authors":"Egarit Noulsri , Surada Lerdwana","doi":"10.1016/j.mehy.2025.111767","DOIUrl":"10.1016/j.mehy.2025.111767","url":null,"abstract":"<div><div>β-thalassemia, a prevalent hereditary hematological condition, is associated with multi-organ impairment, including well-documented neurological complications. These neurological sequelae are primarily attributed to chronic anemia and iron overload-induced neurotoxicity. While existing diagnostic methods assess neurological deficits, a more practical and sensitive strategy is critically needed for early detection and effective treatment monitoring in β-thalassemia patients. A comprehensive review of the literature provides compelling evidence that 1) diverse cell types within the central nervous system (CNS) release specific microparticles (MPs); 2) the concentrations of these MPs in biological fluids are directly influenced by pathological damage to their originating cells; and 3) the unique pathological state of β-thalassemia e.g., oxidative stress, hypoxia, inflammation actively contributes to this MP release. Therefore, we hypothesize that elevated concentrations of CNS-derived MPs in β-thalassemia patients will directly correlate with the severity of neurological abnormalities and CNS injury. If rigorously validated through further <em>in vivo</em> and clinical studies, our proposed MP-based assessment could represent a novel and practical approach for determining the early stages of neurological involvement and effectively monitoring CNS recovery following therapy in β-thalassemia.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111767"},"PeriodicalIF":0.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vanessa Cavalcante-Silva , Marise Samama , Allan Chiaratti de Oliveira , Vânia D’Almeida , Frida Entezami , Sergio Tufik , Monica L. Andersen
{"title":"Could sleep deprivation and changes in maternal microbiota during early pregnancy raise the risk of neural tube and heart malformations?","authors":"Vanessa Cavalcante-Silva , Marise Samama , Allan Chiaratti de Oliveira , Vânia D’Almeida , Frida Entezami , Sergio Tufik , Monica L. Andersen","doi":"10.1016/j.mehy.2025.111764","DOIUrl":"10.1016/j.mehy.2025.111764","url":null,"abstract":"<div><div>Neural tube and heart malformations are major congenital anomalies influenced by genetic and environmental factors, including elevated maternal homocysteine (Hcy) levels. Elevated Hcy levels have been linked to nutritional deficiencies, particularly in folate and cobalamin, as well as with genetic variations in key metabolic enzymes such as methionine synthase (MS), methylenetetrahydrofolate reductase (MTHFR), and cystathionine β-synthase. We hypothesize that elevated Hcy, which has been associated with impaired fetal development, may be influenced by gut microbiota imbalances and sleep disturbances. The gut microbiota is thought to contribute to Hcy metabolism, partly through the production of essential vitamins such as B12 and folate. In this context, dysbiosis, which may be exacerbated by hormonal changes during pregnancy and by sleep deprivation, reflecting a hypomethylated environment. This hypomethylation can adversely affect gene expression and embryonic and fetal development. Strategies to improve maternal sleep quality and support microbiota health, together with folate supplementation, have been suggested to modulate Hcy levels and potentially benefit pregnancy outcomes and fetal development.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111764"},"PeriodicalIF":0.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gretel S. Major , Cara A. Timpani , Aaron P. Russell , Emma Rybalka , Angus Lindsay
{"title":"Considering the potential of ovarian hormones in rescuing neurological phenotypes in Duchenne muscular dystrophy – it’s time to think beyond the muscles","authors":"Gretel S. Major , Cara A. Timpani , Aaron P. Russell , Emma Rybalka , Angus Lindsay","doi":"10.1016/j.mehy.2025.111766","DOIUrl":"10.1016/j.mehy.2025.111766","url":null,"abstract":"<div><div>Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disease that causes premature mortality in young boys. While muscle degeneration is the central cause of death, a myriad of other comorbidities, including neurological dysfunction, afflict boys with DMD throughout their life − yet addressing these secondary dysfunctions has been largely overlooked. This has contributed to a poor mechanistic understanding of neurological comorbidities, a lack of specific clinical treatments and, therefore, a reduced quality of life for patients with DMD. Despite years of near exclusive focus on both pharmacological and genetic therapies to improve muscular phenotypes, there remains limited treatments for DMD. It is time to broaden the therapeutic scope to address the neurological phenotypes in DMD, which may improve patient and family quality of life. Transdisciplinary literature across the field of DMD and other neurological disorders provides evidence that ovarian hormones (oestrogen and progesterone) could play a role in rescuing aspects of neurobehavioural and cognitive dysfunction. Yet given the complexities of systemic endocrine hormone signalling, and a likely negative bias in treating males with female sex hormones, only rudimentary investigations in this area have been conducted. We propose that neurological comorbidities in DMD may stem not only by the absence of dystrophin in the brain, but also from peripheral endocrine control. This hypothesis explores the potential of these peripheral pathways—specifically through ovarian hormones or their receptor modulators—as a novel strategy to improve neurological dysfunction in DMD.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111766"},"PeriodicalIF":0.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is iron dysregulation in the mirror motor cortex associated with misophonia?","authors":"Pradeep Dheerendra , Soumita Ramesh","doi":"10.1016/j.mehy.2025.111765","DOIUrl":"10.1016/j.mehy.2025.111765","url":null,"abstract":"<div><div>Iron homeostasis plays a critical role in brain function and mental health, yet its dysregulation in specific psychiatric conditions remains underexplored. In this article, we propose iron accumulation in the brains of individuals with misophonia—a condition characterized by intense emotional and physiological reactions to specific human-generated sounds. Based on the known involvement of the mirror neuron system in misophonia, we hypothesize that excessive iron concentration in the mirror motor cortex is a result of abnormal hyperactivity in this region. We propose that chronic overactivation of mirror motor cortex leads to increased metabolic demand and elevated cerebral blood flow, facilitating excessive iron influx. This may trigger low-grade chronic neuroinflammation, promoting maladaptive synaptic plasticity and long-term potentiation. The resulting impaired inhibitory control and heightened functional connectivity with primary sensory areas may further exacerbate hyper-mirroring. We propose future studies should confirm the existence of this self-perpetuating cycle which would imply that interventions aimed at reducing mirror system hyperactivity could disrupt this cycle and offer a promising therapeutic strategy for misophonia.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"204 ","pages":"Article 111765"},"PeriodicalIF":0.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145157197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}